Cytotoxic treatment including embolization/chemoembolization for neuroendocrine tumours
- 31 March 2007
- journal article
- review article
- Published by Elsevier BV in Best Practice & Research Clinical Endocrinology & Metabolism
- Vol. 21 (1), 131-144
- https://doi.org/10.1016/j.beem.2007.01.005
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- ChemotherapyBest Practice & Research Clinical Gastroenterology, 2005
- Biotherapy for metastatic endocrine tumoursBest Practice & Research Clinical Gastroenterology, 2005
- Phase II/III Study of Doxorubicin With Fluorouracil Compared With Streptozocin With Fluorouracil or Dacarbazine in the Treatment of Advanced Carcinoid Tumors: Eastern Cooperative Oncology Group Study E1281Journal of Clinical Oncology, 2005
- Current Status of Gastrointestinal CarcinoidsGastroenterology, 2005
- Enteroendocrine Tumors Other Than Carcinoid: A Review of Clinically Significant AdvancesGastroenterology, 2005
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI Journal of the National Cancer Institute, 2000
- Prognostic variables in patients with gastrointestinal carcinoid tumoursBritish Journal of Surgery, 1994
- Streptozocin–Doxorubicin, Streptozocin–Fluorouracil, or Chlorozotocin in the Treatment of Advanced Islet-Cell CarcinomaNew England Journal of Medicine, 1992
- Carcinoid TumorsArchives of Surgery, 1982
- TREATMENT OF MULTIPLE-HORMONE-PRODUCING MALIGNANT ISLET-CELL TUMOUR WITH STREPTOZOTOCINThe Lancet, 1968